| 产品编号 | 结构式 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| T865507 |
| 三甘醇单苄醚, ≥97% Triethylene Glycol Monobenzyl Ether, ≥97% |
C13H20O4 | |
| T866400 |
| 三乙二醇单(2-丙炔基)醚, ≥96% Triethylene Glycol Mono(2-propynyl) Ether, ≥96% |
C9H16O4 | |
| T877152 |
| 2-(2,6-二氧代-哌啶-3-基)-4-氟基-异吲哚-1,3-二酮, ≥98% 2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione, ≥98% |
C13H9FN2O4 | |
| T878761 |
| Thalidomide-OH, ≥99% Thalidomide-OH, ≥99% |
C13H10N2O5 | |
| T880224 |
| TD-106 , ≥99% TD-106 , ≥99% |
C12H11N5O3 | |
| T880402 |
| dTRIM24 , 98% dTRIM24 , 98% |
C55H68N8O13S2 | |
| T880546 |
| Thalidomide-O-amido-C4-N3, 95% Thalidomide-O-amido-C4-N3, 95% |
C19H20N6O6 | |
| T880835 |
| Thalidomide-O-amido-PEG3-C2-NH2 (TFA), ≥99% Thalidomide-O-amido-PEG3-C2-NH2 (TFA), ≥99% |
C25H31F3N4O11 | |
| T880836 |
| Thalidomide-O-amido-PEG2-C2-NH2 (TFA), ≥99% Thalidomide-O-amido-PEG2-C2-NH2 (TFA), ≥99% |
C23H27F3N4O10 | |
| T884711 |
| Thalidomide-O-COOH, 95% Thalidomide-O-COOH, 95% |
C15H12N2O7 | |
| T886447 |
| 1,3,4,6-四-氧-乙酰基-2-[(叠氮乙酰基)氨基]-2-脱氧-β-D-吡喃半乳糖, ≥98% 1,3,4,6-Tetra-O-acetyl-2-[(azidoacetyl)amino]-2-deoxy-β-D-galactopyranos, ≥98% |
C16H22N4O10 | |
| T889137 |
| 2-(2-(苄氧基)乙氧基)乙酸叔丁酯, 90% tert-butyl 2-(2-(benzyloxy)ethoxy)acetate, 90% |
C15H22O4 | |
| T889346 |
| 2-(四氢-2H-吡喃-2-氧基)乙醇, ≥95% 2-(TETRAHYDRO-2H-PYRAN-2-YLOXY)ETHANOL, ≥95% |
C7H14O3 | |
| T897486 |
| 2,5,8,11-四氧杂十三烷-13-基4-甲基苯磺酸酯, 95% 2,5,8,11-Tetraoxatridecan-13-yl 4-methylbenzenesulfonate, 95% |
C16H26O7S | |
| T903546 |
| (2-(2-(丙-2-炔-1-氧基)乙氧基)乙基)氨基甲酸叔丁酯, 90% tert-butyl (2-(2-(prop-2-yn-1-yloxy)ethoxy)ethyl)carbamate, 90% |
C12H21NO4 | |
| T903547 |
| (3,6,9,12-四氧杂戊癸-14-炔-1-基)氨基甲酸叔丁酯, 90% tert-butyl (3,6,9,12-tetraoxapentadec-14-yn-1-yl)carbamate, 90% |
C16H29NO6 | |
| T905405 |
| 3-(2-溴乙氧基)丙酸叔丁酯, 95% Tert-Butyl 3-(2-bromoethoxy)propanoate, 95% |
C9H17BrO3 | |
| T910553 |
| Thalidomide-O-amido-C3-NH2, 98% Thalidomide-O-amido-C3-NH2, 98% |
C20H21F3N4O8 | |
| T910559 |
| dTAG-13, 98% dTAG-13, 98% |
C57H68N4O15 | |
| T910630 |
| TGN-020, 98% TGN-020, 98% |
C8H6N4Os |